✦ LIBER ✦

USE OF THE CHADS2 AND CHA2DS2-VASC SCORE IN JAPANESE PATIENTS WITH ATRIAL FIBRILLATION: A SUB-ANALYSIS OF THE JAPAN THROMBOSIS REGISTRY FOR ATRIAL FIBRILLATION, CORONARY OR CEREBROVASCULAR EVENTS (J-TRACE)

✍ Scribed by Eri Toda; Gregory YH Lip; Shinichiro Uchiyama; Kazyuyuki Shimada; Hideki Origasa; Hiroyuki Kobayashi; Akio Kawamura; Kazuo Kitagawa; Takehiko Nagao; Yasuo Ikeda; Shinya Goto

Book ID: 118582484
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 98 KB
Volume: 59
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(12)60675-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The value of the CHA2DS2-VASc score for

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study :

✍ Olesen, J. B.; Torp-Pedersen, C.; Hansen, M. L.; Lip, G. Y. H. 📂 Article 📅 2012 🏛 Schattauer 🌐 English ⚖ 442 KB

The CHADS2 versus the New CHA2DS2-VASc S

The CHADS2 versus the New CHA2DS2-VASc Scoring Systems for Guiding Antithrombotic Treatment of Patients with Atrial Fibrillation: Review of the Literature and Recommendations for Use

✍ Lauren E. Odum; Kelly A. Cochran; Daniel S. Aistrope; Kathleen A. Snella 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

PRM26 The Use of Claims-Based CHA2DS2-VA

PRM26 The Use of Claims-Based CHA2DS2-VASc and ATRIA Scores to Predict Stroke/Systemic Embolism and Bleeding Rates Among Anticoagulated Patients With Atrial Fibrillation (AFIB) in a Pharmacy-Benefit Management (PBM) Environment

✍ D.C. Malone; S.L. Charland; B.C. Agatep; V. Herrera; G.S. Hawk; B.J. Schrader; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB